Advertisement

Topics

Bonti Announces Start of LANTERN-1 Phase 2 Clinical Study Evaluating EB-001 in Reducing ...

04:06 EDT 23 Aug 2017 | BioMedReports - Blog

Interim Data Anticipated by Year-end 2017

Read more...

Original Article: Bonti Announces Start of LANTERN-1 Phase 2 Clinical Study Evaluating EB-001 in Reducing ...

NEXT ARTICLE

More From BioPortfolio on "Bonti Announces Start of LANTERN-1 Phase 2 Clinical Study Evaluating EB-001 in Reducing ..."

Advertisement
Quick Search
Advertisement
Advertisement